Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Recruiting now · Not applicable
Conditions studied: Hepatitis B, Hepatitis C, AIDS
In brief
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
Key facts
- Study ID
- NCT05390424
- Run by
- University Hospital, Rouen
- People needed
- 500
- Starts
- 2022-12-02
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2026-02-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Former or active intravenous and/or nasal drug user
- Person on opiate substitution therapy
You may not qualify if…
- Person with known active viral infection(s)
Where it is running
- Caarud Sud Manche — Avranches, France (enrolling)
- Csapa Barentin — Barentin, France (enrolling)
- Oeuvre Normande Des Meres — Dieppe, France (enrolling)
- Csapa Act — Elbeuf, France (enrolling)
- Csapa Gisors — Gisors, France (enrolling)
- Csapa Nautilia — Le Havre, France (enrolling)
- Csapa Pont-Audemer — Pont-Audemer, France (enrolling)
- Aides Region Normandie — Rouen, France (enrolling)
- Csapa-Caarud La Boussole — Rouen, France (enrolling)
- Chu Rouen — Rouen, France (enrolling)
- Csapa Caux Et Bray — Yvetot, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.